A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
Clinical trial NCT06436742 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06436742
- Sponsor
- argenx
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-24
- Primary completion
- 2027-08-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.